Clinical Trials › NCT05704361
RecruitingPhase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
Sponsored by Hoffmann-La Roche
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 129
Target enrollment
5
U.S. states
Aug 2021
Start date
Jul 2027
Expected completion
Interventions / Treatments
RO7121932 IVRO7121932 SC
Conditions studied
Multiple Sclerosis
Where this trial is running (5 sites)
California1 site
Stanford
Connecticut1 site
New Haven
Florida1 site
Tampa
Massachusetts1 site
Worcester
Ohio1 site
Cincinnati
Participating MS centers on MS Buddy (3)
USF Multiple Sclerosis Center
Tampa, FL
Tampa, FL
The Waddell Center for Multiple Sclerosis
Cincinnati, OH
Cincinnati, OH
Stanford MS & Neuroimmunology Clinic
Palo Alto, CA
Palo Alto, CA
MS centers in California
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View California centersMore Phase 1 trials
Browse all Phase 1 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
